---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-245602"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:24:23.280955+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics Chairman James Huang resigns; Holger Weis elected successor

## Summary
- James Huang resigned as Chairman and board member effective September 22, 2023.
- Resignation not due to any disagreement on operations, policies, or practices.
- Board elected Holger Weis as new Chairman of the Board.

## SEC filing metadata
- accession: 0001193125-23-245602
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/d469943d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-245602
- JSON: https://secwatch.observer/filing/0001193125-23-245602.json
- Plain text: https://secwatch.observer/filing/0001193125-23-245602.txt

## Key facts
- Executive change
  Holger Weis was elected as Chairman at Alaunos Therapeutics, Inc..
  - Action: elected
  - Role: Chairman
  source text: With Mr. Huang’s departure, the Board has elected Holger Weis as the Company’s new Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm
- Executive change
  James Huang resigned as Chairman at Alaunos Therapeutics, Inc..
  - Action: resigned
  - Role: Chairman
  source text: On September 22, 2023, James Huang resigned as Chairman and member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect in order to focus on other business pursuits.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.